Brian R. Murphy mainly focuses on Virology, Virus, Antibody, Immunology and Titer. His Virology research includes elements of Recombinant virus and Recombinant DNA. His research in Virus intersects with topics in Human metapneumovirus and Antigen.
His Antigen research is multidisciplinary, incorporating elements of Excretion and Neuraminidase. His Antibody study deals with Respiratory tract intersecting with Microbiology. As a part of the same scientific family, Brian R. Murphy mostly works in the field of Titer, focusing on Reactogenicity and, on occasion, Antibody titer.
Brian R. Murphy focuses on Virology, Virus, Influenza A virus, Immunology and Optoelectronics. His research investigates the connection between Virology and topics such as Gene that intersect with issues in Molecular biology. His Virus research includes themes of Recombinant virus, Antigen and Vaccination.
His research integrates issues of Influenza A virus subtype H5N1, Viral shedding and Virulence in his study of Influenza A virus. His Viral replication study incorporates themes from Human metapneumovirus, Metapneumovirus and Viral Vaccine. He has researched Titer in several fields, including Infectivity, Paramyxoviridae and Reactogenicity.
His scientific interests lie mostly in Virology, Computer hardware, Cartridge, Optoelectronics and Virus. Virology is closely attributed to Immunology in his research. His Computer hardware research includes elements of Synchronization, State, State information and Chip.
His research on Cartridge also deals with topics like
His main research concerns Virology, Cartridge, Flavivirus, Dengue fever and Immunology. His work on Virology is being expanded to include thematically relevant topics such as Silent mutation. Brian R. Murphy interconnects Fluidics, Microfluidic chip, Microfluidics and Optoelectronics in the investigation of issues within Cartridge.
His Flavivirus study introduces a deeper knowledge of Virus. His studies deal with areas such as Attenuated vaccine, Neutralizing antibody, Original antigenic sin and Vaccination as well as Dengue fever.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Maximizing multiprocessor performance with the SUIF compiler
Mary W. Hall;Jennifer-Ann M. Anderson;Saman P. Amarasinghe;Brian R. Murphy.
IEEE Computer (1996)
Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development
Peter L. Collins;Myron G. Hill;Ena Camargo;Haim Grosfeld.
Proceedings of the National Academy of Sciences of the United States of America (1995)
Immune Response to Dengue Virus and Prospects for a Vaccine
Brian R Murphy;Stephen S Whitehead.
Annual Review of Immunology (2011)
Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity
Robert A. Olmsted;Narayanasamy Elango;Gregory A. Prince;Brian R. Murphy.
Proceedings of the National Academy of Sciences of the United States of America (1986)
Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice
Kanta Subbarao;Josephine McAuliffe;Leatrice Vogel;Gary Fahle.
Journal of Virology (2004)
Compiler and runtime support for efficient software transactional memory
Ali-Reza Adl-Tabatabai;Brian T. Lewis;Vijay Menon;Brian R. Murphy.
programming language design and implementation (2006)
Association of Serum Anti-Neuraminidase Antibody with Resistance to Influenza in Man
Brian R. Murphy;Julius A. Kasel;Robert M. Chanock.
The New England Journal of Medicine (1972)
Genetic diversity between human metapneumovirus subgroups
Stéphane Biacchesi;Mario H Skiadopoulos;Guy Boivin;Christopher T Hanson.
Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees.
Michael N. Teng;Stephen S. Whitehead;Alison Bermingham;Marisa St. Claire.
Journal of Virology (2000)
Recombinant Human Metapneumovirus Lacking the Small Hydrophobic SH and/or Attachment G Glycoprotein: Deletion of G Yields a Promising Vaccine Candidate
Stéphane Biacchesi;Mario H. Skiadopoulos;Lijuan Yang;Elaine W. Lamirande.
Journal of Virology (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: